- Home
- BEAT vs BYFC Comparison
BEAT vs BYFC Comparison
Compare BEAT & BYFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- BYFC
- Stock Information
- Founded
- BEAT 2015
- BYFC 1946
- Country
- BEAT United States
- BYFC United States
- Employees
- BEAT N/A
- BYFC N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- BYFC Savings Institutions
- Sector
- BEAT Technology
- BYFC Finance
- Exchange
- BEAT Nasdaq
- BYFC Nasdaq
- Market Cap
- BEAT 57.6M
- BYFC 67.5M
- IPO Year
- BEAT 2021
- BYFC 1996
- Fundamental
- Price
- BEAT $1.63
- BYFC $6.69
- Analyst Decision
- BEAT Buy
- BYFC
- Analyst Count
- BEAT 1
- BYFC 0
- Target Price
- BEAT $8.00
- BYFC N/A
- AVG Volume (30 Days)
- BEAT 73.9K
- BYFC 2.9K
- Earning Date
- BEAT 11-07-2025
- BYFC 10-31-2025
- Dividend Yield
- BEAT N/A
- BYFC N/A
- EPS Growth
- BEAT N/A
- BYFC N/A
- EPS
- BEAT N/A
- BYFC N/A
- Revenue
- BEAT N/A
- BYFC $33,412,000.00
- Revenue This Year
- BEAT N/A
- BYFC N/A
- Revenue Next Year
- BEAT $19.35
- BYFC N/A
- P/E Ratio
- BEAT N/A
- BYFC N/A
- Revenue Growth
- BEAT N/A
- BYFC N/A
- 52 Week Low
- BEAT $0.91
- BYFC $5.71
- 52 Week High
- BEAT $3.48
- BYFC $9.46
- Technical
- Relative Strength Index (RSI)
- BEAT 49.06
- BYFC 30.69
- Support Level
- BEAT $1.53
- BYFC $7.06
- Resistance Level
- BEAT $1.81
- BYFC $7.17
- Average True Range (ATR)
- BEAT 0.12
- BYFC 0.13
- MACD
- BEAT -0.03
- BYFC -0.07
- Stochastic Oscillator
- BEAT 25.00
- BYFC 5.69
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.